SOURCE: iSatori

iSatori

November 14, 2013 10:00 ET

iSatori Secures Expanded Bank Line of Credit Through Renewed Seven-Year Colorado Banking Relationship

GOLDEN, CO--(Marketwired - Nov 14, 2013) - iSatori, Inc. (OTCQB: IFIT), an emerging leader in the development and marketing of scientifically engineered nutritional supplements for healthier lifestyles, today announced that CoBiz Bank of Denver, Colorado, has renewed its commercial bank line of credit availability for iSatori to $1.5 million based on the Company's performance and assets.

This renewed borrowing relationship is under the same terms, conditions, and borrowing base covenants of the prior line of credit, although it has been expanded 13 months. The credit facility will operate as a revolving line of credit through 2014. This additional borrowing capacity will allow the Company to support its growth in food, drug, and mass merchandisers throughout the United States. This growth capital is expected to propel the Company's momentum in Fortune 500 suppliers such as Walmart, Rite-Aid, Walgreens, and others.

Commenting upon these developments, iSatori's Chief Executive Officer, Stephen Adele, noted, "We are excited we have secured the necessary bank capital to propel us further into major food, drug, and mass retail distribution. Our flag-ship product, Energize, is successfully competing against the leading existing energy products and continues to make substantial inroads. As a result, we will continue to look to our long-standing banking relationship with CoBiz for the Company's future needs in supporting our expansion."

About iSatori, Inc.

iSatori, Inc. is a consumer products firm that develops and sells nutritional products in the performance, weight loss, and energy markets through online marketing, Fortune 500 retailers, and thousands of retail stores around the world. More information about the Company is available at www.iSatori.com.

Forward-Looking Statements

Statements made in this news release relating to the Company's future sales, expenses, revenue, product developments, and all other statements except statements of historical fact, are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements are based on assumptions and estimates that management believes are reasonable based on currently available information; however, management's assumptions and the Company's future performance are both subject to a wide range of business risks and uncertainties, and there is no assurance that these goals and projections can or will be met. Any number of factors could cause actual results to differ materially from those in the forward-looking statements, including, but not limited to, the timing and extent of changes in demand for the Company's products, the availability and price of ingredients necessary to manufacture such products, and the outcome of any current or future litigation regarding such products or similar products of competitors. All forward-looking statements are made only as of the date hereof, and the Company undertakes no obligation to update any such statement.